Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-04-22 | Century Therapeutics, Inc. | Russotti Gregory
(See Remarks) |
S | Common Stock | D | 5000 | $3.10 - $3.10 | $15,489 |
2024-03-07 | Century Therapeutics, Inc. | Pfeiffenberger Brent
(President and CEO) |
A | Common Stock | A | 17425 | $0.00 - $0.00 | $0 |
2024-03-07 | Century Therapeutics, Inc. | Carr Douglas
(SVP Finance & Operations) |
A | Common Stock | A | 14000 | $0.00 - $0.00 | $0 |
2024-03-07 | Century Therapeutics, Inc. | Russotti Gregory
(See Remarks) |
A | Common Stock | A | 24000 | $0.00 - $0.00 | $0 |
2024-03-07 | Century Therapeutics, Inc. | Farid Adrienne
(Chief Operations Officer) |
A | Common Stock | A | 24000 | $0.00 - $0.00 | $0 |
2024-03-07 | Century Therapeutics, Inc. | Levitsky Hyam
(President of R&D) |
A | Common Stock | A | 24000 | $0.00 - $0.00 | $0 |
2024-03-06 | Century Therapeutics, Inc. | Farid Adrienne
(Chief Operations Officer) |
S | Common Stock | D | 53515 | $4.96 - $5.14 | $269,681 |
2024-03-06 | Century Therapeutics, Inc. | Farid Adrienne
(Chief Operations Officer) |
M | Common Stock | A | 53515 | $1.03 - $1.03 | $55,119 |
2024-02-05 | Century Therapeutics, Inc. | Carr Douglas
(SVP Finance & Operations) |
S | Common Stock | D | 1200 | $3.84 - $4.49 | $4,968 |
2023-12-04 | Century Therapeutics, Inc. | Pfeiffenberger Brent
(President and CEO) |
A | Common Stock | A | 1453279 | $0.00 - $0.00 | $0 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |